Tinzaparin use in pregnancy: An international, retrospective study of the safety and efficacy profile

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 159, Issue 2, 2011, Pages 293-299

  Nelson Piercy, Catherine ^a   Powrie, Raymond ^b   Borg, Jean Yvonne ^c   Rodger, Marc ^d   Talbot, David J ^e   Stinson, John ^f   Greer, Ian A ^g  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e Princes Risborough   (United Kingdom)

^f LEO Pharma   (Ireland)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Low molecular weight heparin; Pregnancy; Prophylaxis; Treatment; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; ANESTHESIA INDUCTION; ANTICOAGULANT THERAPY; ARTICLE; BELGIUM; CANADA; CESAREAN SECTION; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELIVERY; DENMARK; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FEMALE; FETUS; FRAGILITY FRACTURE; HEMATOLOGY; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL; HUMAN; INJECTION SITE HEMATOMA; INTERVENTION STUDY; IRELAND; LIVE BIRTH; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MATERNAL BLEEDING; MATERNAL MORTALITY; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MEDICAL EXPERT; MEDICAL RECORD; MULTICENTER STUDY; NEONATAL HEMORRHAGE; NETHERLANDS; NEWBORN; OBSTETRICS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPAIN; SPONTANEOUS ABORTION; STILLBIRTH; SWEDEN; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; VENOUS THROMBOEMBOLISM; WOUND HEMATOMA;

EID: 82255162754     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.08.005     Document Type: Article

References (19)

1. J.A. Heit, C.E. Kobbervig, and A.H. James Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study Ann Intern Med 143 2005 697 706
2. S.M. Bates, I.A. Greer, and I. Pabinger Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn) Chest 133 6 Suppl. 2008 844S 886S
3. G. Bourjeily, M. Paidas, and H. Khalil Pulmonary embolism in pregnancy Lancet 375 9713 2010 500 512
4. I.A. Greer, and C. Nelson-Piercy Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy Blood 106 2005 401 407
5. P. Marik, and L. Plante Venous thromboembolic disease and pregnancy N Engl J Med 359 2008 2025 2033
6. R.D. Hull, G.E. Raskob, and G.F. Pineo Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis N Engl J Med 326 1992 975 982
7. G. Simonneau, H. Sars, and B. Charbonnier A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism N Engl J Med 337 1997 663 669
8. M.P. Smith, L.A. Norris, and P.J. Steer Tinzaparin sodium for thrombosis treatment and prevention during pregnancy Am J Obstet Gynecol 190 2004 495 501
9. Centre for Maternal and Child Enquiries (CMACE) Perinatal Mortality 2009: United Kingdom. CMACE: London, 2011. Accessed: 18 April 2011. Available at: http://www.cemach.org.uk/getattachment/87faf695-b2cb-43d0-8eb8-9c2260789ee4/ Perinatal-Mortality-2009.aspx.
10. J. Voke, J. Keidan, and S. Pavord The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey Br J Haematol 139 2007 545 558
11. M. Knight, and UK Obstetric Surveillance System (UKOSS) Antenatal pulmonary embolism: risk factors, management and outcomes Br J Obstet Gynaecol 115 2008 453 461
12. A. Jindal, J. Luckit, A. Govind, and W. Yoong Treatment of established thrombosis in pregnancy with tinzaparin, a study of 32 patients for one centre Pathophysiol Haemost Thromb 35 2006 A50
13. L.M. Byrd, C.R. Schiach, C.R.M. Hay, and T.A. Johnston Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated? J Obstet Gynecol 28 2008 539 542
14. J. Sabadell, M. Casellas, and J. Alijotas-Reig Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes Eur J Obstet Gynecol Reprod Biol 149 2010 47 51
15. B.J. Hunt, H.A. Doughty, and G. Majumbdar Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies Thromb Haemost 77 1997 39 43
16. R.M. Bauersachs, J. Dudenhausen, and A. Faridi Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women Thromb Haemost 98 2007 1237 1245
17. E. Lefkou, M. Khamashta, G. Hampson, and B.J. Hunt Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity? Lupus 19 2010 3 12
18. V. Pettila, P. Leinonen, A. Markkola, and V. Hiilesmaa Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin Thromb Haemost 87 2002 182 186
19. M.A. Rodger, S.R. Kahn, and A. Cranney Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial J Thromb Haemost 5 2007 1600 1606